SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (7281)12/11/1999 2:22:00 PM
From: Pseudo Biologist  Read Replies (1) of 9719
 
That is.... bex plus less flu tox equals better, but C2B8 plus less flu tox might not be as good as bex plus less flu tox.

OK, here is an updated version of berblady's rankings:

(1) Toxicity from less to more:

Rituxan < Bex ~ Zev, Rit + Flu3 ~ Bex + Flu3 (guess) < Rit + Flu6 ~ Rit + CHOP (another guess, Rit+Flu6 could be actually more toxic, but we do not have enough data). Not known but interesting to think about Zev+Flu3, Zev+CHOP, Bex+CHOP?

(2) Efficacy from less to more:

Ritux < Bex ~ Zev < Ritux + Flu3 (guess) < Ritux+CHOP ~ Bex+Flu3 and Rit+Flu6??

I'll leave the cost rankings to Peter -g-

PB
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News